Publications

Johnson G, Rajendran P, Li L, Chen Y, Dashwood W, Nguyen N, Ulusan A, Ertem F,  Zhang M, Sun D, Huang Y, Wang S, Leung H, Lieberman D, Beaver L, Ho Emily, Bedford   Mark, Chang K, Vilar E, Dashwood R. (2019) CCAR2 acetylation establishes a   BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain   inhibition. Cancer Research 79 (13 Supplement), 2614-2614     

Lei Guo, Jia Li, Hongxiang Zeng, Anna Guzman, Tingting Li, Minjung Lee, Yubin Zhou, Clifford Stephan, Peter JA Davies, Margaret Goodell, Deqiang Sun, Mark A Dawson, Yun Huang. (2019) A Combination   Strategy Targeting Enhancer Plasticity Exerts Synergistic Lethality Against   Beti-Resistant Leukemia Cells. Blood, The Journal of the American Society of Hematology 134

Zhang J, Tan P, Guo L, Gong J, Ma J, Li J, Lee M, Fang S, Jing J, Johnson G, Sun D, Cao W, Dashwood R, Han L, Zhou Y, Dong W, Huang Y. (2018) p53-dependent autophagic degradation of TET2 modulates cancer   therapeutic resistance. Blood 132 (Suppl 1), 2610

Fang S, Xiao Y, Li J, Li T, Zeng H, Han W, Zhou Y, Sun D, Martin J, Huang Y. (2018) Tet2 Deficiency in Macrophages Undermines Heart Repair after Infarction. Blood 132 (Suppl 1), 2394

Guo L, Li J, Fang S, Lee M, Zeng H, Li T, Han W, Sun D, Huang Y. (2018) Synthetic Lethality of Combinatory Inhibition of BET and CDK7 in BET (i) Resistant Leukemia Cells. Blood 132 (Suppl 1), 1354-1354

Lee M, Zeng H, Li J, Han W, Sun D, Huang Y. (2018) Disruption of TET2 Dioxygenase Enhances Antitumor Efficiency in CD8+ Tumor Infiltrating Lymphocytes. Blood 132 (Suppl 1), 860-860     

F Ertem, W Zhang, K Chang, W Dashwood, P Rajendran, D Sun, A Abudayyeh, M Abdulrahim, E Vilar, R Dashwood. (2017) Prevention by tolfenamic acid and characterization of the molecular targets in Pirc and FAP colorectal adenomas. Cancer Research 77 (13 Supplement), 2229

S Zang, J Li, H Yang, W Han, J Zhang, M Lee, Y Zhou, D Sun, Y Huang. (2017) TET2 loss and the lymphoma-associated RHOA mutation cooperate to disrupt CD4+T cell function. Cancer Research 77 (13 Supplement), 5379

K King, K Matatall, S Chen, M Jeong, D Sun, F Chen, Q Mo, M Kimmel. (2016) Terminal differentiation is the major route of   HSC loss during chronic infection. Experimental Hematology 44 (9), S44 

K King, K Matatall, S Chen, M Jeong, D Sun, F Chen, Q Mo, M Kimmel. (2016) Terminal Differentiation Is the Major Route of   Hematopoietic Stem Cell Loss During Chronic Infection. Open Forum Infectious   Diseases 3 (suppl 1), 901

G Challen, A Mayle, D Sun, et. al.. (2013) De novo DNA methylation is required for maintaining genomic and transcriptional   integrity in hematopoietic stem cells. Experimental Hematology 41 (8), S14.

A Mayle, D Sun, M Jeong, et. al.. (2013) Dnmt3b Has Few Specific Functions In Adult Hematopoietic Stem Cells But Shows   Abnormal Activity In The Absence Of Dnmt3a. Blood 122 (21):734.

M Jeong, D Sun, HJ Park, et. al.. (2013) Long Non-Coding RNAs Control Hematopoietic Stem Cells (HSC) Function. Blood 122 (21):48. 

M Jeong, D Sun, M Luo, et. al.. (2013) Large Conserved Domains Of Low DNA Methylation Maintained By 5-Hydroxymethycytosine and Dnmt3a. Blood 122 (21):2406.

A Mayle, GA Challen, D Sun, et. al.. (2012) Dnmt3b Is Dispensable for Hematopoietic Stem Cell Differentiation, but Acts   Synergistically with Dnmt3a to Control the Balance Between Self-Renewal and   Differentiation.  Blood 120 (21).

M Jeong, M Luo, D Sun, et. al.. (2012) HSC Aging Epigenome: Widespread Alterations in DNA Methylation and Transcription.  Blood 120 (21).

A Kosters, D Sun, F Tian, et. al.. (2012) Novel sex-differential Retinoid X Receptor alpha binding sites in mouse liver by genome-wide chromatin analysis. Hepatology 56, 245A.

M Jeong, D Sun, M Luo, et. al.. (2011) Genome Wide DNA Methylation and Transcriptome Analysis in HSC Aging. Blood 118 (21), 1020.